Sequenom to Petition U.S. Supreme Court to Regain MaterniT21 Test Patent

摘要

With its sales and margins suffering unrelenting pressure, the beleaguered molecular testing firm Sequenom has decided to petition the United States Supreme Court in an attempt to regain a patent for a genetic test it lost three years ago.